DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
04 sept. 2020 10h00 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of NGHC, GOCO, PSTX, and PROG; Shareholders are Encouraged to Contact the Firm
03 sept. 2020 09h00 HE
|
Barr Law Group
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- If you own any of the above stocks and would like to discuss your legal rights, please email leo@barrlaw.com or call (619) 400-4966. ...
Progenity to Participate in Two Upcoming Investor Conferences
02 sept. 2020 07h30 HE
|
Progenity, Inc.
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
PROGENITY ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Progenity, Inc. and Encourages Investors to Contact the Firm
31 août 2020 11h20 HE
|
Bragar Eagel & Squire
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United...
PROGENITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progenity, Inc. on Behalf of Progenity Stockholders and Encourages Investors to Contact the Firm
28 août 2020 16h00 HE
|
Bragar Eagel & Squire
NEW YORK, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Progenity, Inc. (NASDAQ:...
Progenity Commends New Recommendations from ACOG and SMFM Supporting Non-Invasive Prenatal Testing (NIPT) for All Pregnancies
21 août 2020 07h30 HE
|
Progenity, Inc.
SAN DIEGO, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Provides Corporate Updates and Reports Second Quarter 2020 Financial Results
13 août 2020 16h01 HE
|
Progenity, Inc.
Completed initial public offering raising gross proceeds of $100M Reported 75 thousand tests in the second quarter, showing resiliency of business during COVID‑19 pandemic Signed first precision...
Progenity to Report Second Quarter 2020 Financial Results
06 août 2020 16h05 HE
|
Progenity, Inc.
SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Reaches Resolution with Government Related to Past Business, Promotional, and Billing Practices
23 juil. 2020 13h58 HE
|
Progenity, Inc.
SAN DIEGO, July 23, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company focused on providing complex molecular and specialized diagnostic tests to clinicians as well as...